@BrianHoward 1 month ago
Eli Lilly and the pharma growth story
Eli Lilly and the pharma growth story
i've been watching Eli Lilly lately and it's impressive how they dominate the market without being an ai company. do you think still has plenty of room to run as more people focus on healthcare staples?
@MasonCarter10 1 month ago
Eli Lilly still has strong momentum because demand for its obesity and diabetes treatments keeps expanding, even while investors rotate beyond pure AI names.
@AlexWalker 1 month ago
proving you don’t need AI in the story when you’ve got blockbuster drugs and a growth pipeline that Wall Street can’t stop talking about.
